Julian Panes (Julià Panés, Julian Panés, Julián Panés)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 47

Top Topics

Ulcerative Colitis

Top Venues

Journal of Crohn's & colitis

Advances in therapy

Inflammatory bowel diseases

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Florian Rieders, Mark E Baker, David Henry Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif R Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panes, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher, null null
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Julian Panes, Geert R D'Haens, Bruce E Sands, William K K Wu, Nervin Lawendy, Nicole Kulisek, Xiang Guo, Joseph Wu, Ivana Vranic, Remo Panaccione, Severine Vermeire
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure. United European gastroenterology journal 12 (6) (2024)
Julian Panes, Geert R D'Haens, Bruce E Sands, William K K Wu, Nervin Lawendy, Nicole Kulisek, Xiang Guo, Joseph Wu, Ivana Vranic, Remo Panaccione, Severine Vermeire
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure. United European gastroenterology journal 12 (6) (2024)
Florian Rieders, Mark E Baker, David Henry Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif R Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panes, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher, null null
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Andres J Yarur, Michael V Chiorean, Julian Panes, Vipul Jairath, Jinkun Zhang, Christopher J Rabbat, William J Sandborn, Severine Vermeire, Laurent Peyrin-Biroulet
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. Journal of Crohn's & colitis 18 (6) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics (2024)
Julian Panes, Edouard Louis, Peter Bossuyt, Namita Joshi, Wan-Ju Lee, Ana P Lacerda, Kristina Kligys, Si Xuan, Nidhi Shukla, Edward V Loftus
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease. Inflammatory bowel diseases (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panes, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R A M D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Severine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis 18 (8) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy (2024)
Dominik Bettenworth, Mark E Baker, Joel G Fletcher, Vipul Jairath, Cathy Lu, Willem Bemelman, Geert d'Haens, Andre d'Hoore, Axel Dignass, Iris Dotan, Roger Feakins, Phillip Fleshner, Christina Ha, Gaylyn Henderson, Ruishen Lyu, Julian Panes, Gerhard Rogler, Ren Mao, Jordi Rimola, William J Sandborn, William K K Wu, Britta Siegmund, Mark Silverberg, Stuart A Taylor, Bram Verstockt, Ilyssa O Gordon, David H Bruining, Brian G Feagan, Florian Rieder, null null
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn's disease in clinical practice. Nature reviews. Gastroenterology & hepatology 21 (8) (2024)
Julian Panes, Geert R D'Haens, Bruce E Sands, William K K Wu, Nervin Lawendy, Nicole Kulisek, Xiang Guo, Joseph Wu, Ivana Vranic, Remo Panaccione, Severine Vermeire
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure. United European gastroenterology journal 12 (6) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Florian Rieders, Mark E Baker, David Henry Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif R Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panes, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher, null null
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Dominik Bettenworth, Mark E Baker, Joel G Fletcher, Vipul Jairath, Cathy Lu, Willem Bemelman, Geert d'Haens, Andre d'Hoore, Axel Dignass, Iris Dotan, Roger Feakins, Phillip Fleshner, Christina Ha, Gaylyn Henderson, Ruishen Lyu, Julian Panes, Gerhard Rogler, Ren Mao, Jordi Rimola, William J Sandborn, William K K Wu, Britta Siegmund, Mark Silverberg, Stuart A Taylor, Bram Verstockt, Ilyssa O Gordon, David H Bruining, Brian G Feagan, Florian Rieder, null null
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn's disease in clinical practice. Nature reviews. Gastroenterology & hepatology (2024)
Andres J Yarur, Michael V Chiorean, Julian Panes, Vipul Jairath, Jinkun Zhang, Christopher J Rabbat, William J Sandborn, Severine Vermeire, Laurent Peyrin-Biroulet
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. Journal of Crohn's & colitis 18 (6) (2024)
Andres J Yarur, Michael V Chiorean, Julian Panes, Vipul Jairath, Jinkun Zhang, Christopher J Rabbat, William J Sandborn, Severine Vermeire, Laurent Peyrin-Biroulet
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. Journal of Crohn's & colitis 18 (6) (2024)
Julian Panes, Geert R D'Haens, Bruce E Sands, William K K Wu, Nervin Lawendy, Nicole Kulisek, Xiang Guo, Joseph Wu, Ivana Vranic, Remo Panaccione, Severine Vermeire
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure. United European gastroenterology journal (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panes, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R A M D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Severine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis 18 (8) (2024)
Andres J Yarur, Michael V Chiorean, Julian Panes, Vipul Jairath, Jinkun Zhang, Christopher J Rabbat, William J Sandborn, Severine Vermeire, Laurent Peyrin-Biroulet
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. Journal of Crohn's & colitis 18 (6) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Laurent Peyrin Biroulet, Severine Vermeire, Geert D'Haens, Julian Panes, Axel U Dignass, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravatà, Frederic Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R Gaya, Silvio Danese
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST. Alimentary pharmacology & therapeutics (2023)
Julian Panes, Severine Vermeire, Geert R D'Haens, Silvio Danese, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravatà, Daniel R Gaya, Laurent Peyrin Biroulet, Axel U Dignass, null null
Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial. United European gastroenterology journal (2023)
Julian Panes, Edward V Loftus, Peter D R Higgins, James O Lindsay, Wen Zhou, Xuan Yao, Dapo Ilo, Charles Phillips, Jacinda Tran, Yuri Sanchez Gonzalez, Séverine Vermeire
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results. Inflammatory bowel diseases (2023)
Daniel Aguilar, Lluís Revilla, Alba Garrido-Trigo, Julian Panes, Juan J Lozano, Núria Planell, Miriam Esteller, Ana P Lacerda, Heath Guay, James Butler, Justin Wade Davis, Azucena Salas
Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST Study. Inflammatory bowel diseases 27 (12) (2022)
Julian Panes, Gerd Bouma, Marc Ferrante, Torsten Kucharzik, Maria Nachury, Fernando de la Portilla de Juan, Walter Reinisch, Francesco Selvaggi, Jörg Tschmelitsch, Neil R Brett, Martin Ladouceur, Matthias Binek, Gary Hantsbarger, Sarah Campbell-Hill, Chitra Karki, Christianne Buskens
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial. Inflammatory bowel diseases 28 (11) (2022)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy (2022)
Julian Panes, James O Lindsay, Niels Teich, Stefan Lindgren, Jean Frederic Colombel, Heather Ann Flynn, Susan Huyck, Ruji Yao, George Philip, Walter Reinisch
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab. Inflammatory bowel diseases 27 (12) (2022)
Cristina Romero-Mascarell, Gloria Fernández-Esparrach, Cristina Rodríguez-De Miguel, Maria Carme Masamunt, Sonia Rodríguez, Jordi Rimola, Miguel Urpí, Gherzon Simon Casanova, Ingrid Ordás, Elena Ricart, Berta Caballol, Agnès Fernández-Clotet, Julian Panes, Josep Llach, Begoña González Suárez
Fecal Calprotectin for Small Bowel Crohn's Disease: Is It a Cutoff Issue? Diagnostics (Basel, Switzerland) 12 (9) (2022)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy 10 (2) (2022)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy (2022)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy 10 (2) (2022)
Julian Panes, Séverine Vermeire, Marla C Dubinsky, Edward V Loftus, Nervin Lawendy, Wenjin Wang, Leonardo Salese, Chinyu Su, Irene Modesto, Xiang Guo, Jean Frederic Colombel
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials. Journal of Crohn's & colitis 15 (11) (2022)
William J Sandborn, James D Lewis, Julian Panes, Edward V Loftus, Geert D'Haens, Zhuqing Yu, Bidan Huang, Ana P Lacerda, Aileen L Pangan, Brian G Feagan
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease. Journal of Crohn's & colitis (2021)
Séverine Vermeire, Michael Chiorean, Julian Panes, Laurent Peyrin-Biroulet, Jinkun Zhang, Bruce E Sands, Krisztina Lazin, Preston Klassen, Snehal U Naik, Christopher H Cabell, William J Sandborn
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study. Journal of Crohn's & colitis 15 (6) (2021)
Subrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, Ryan Clark, Wangang Xie, Edouard Louis, Edward V Loftus, Julian Panes, Silvio Danese
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis. Journal of Crohn's & colitis (2021)
Jordi Rimola, Julian Panes, Ingrid Ordás
Letter: accuracy of magnetic resonance index of activity score to predict response to biologics in Crohn's disease-authors' reply. Alimentary pharmacology & therapeutics 53 (1) (2021)
Jurij Hanžel, Vipul Jairath, Peter De Cruz, Leonardo Guizzetti, Lisa M Shackelton, Peter Bossuyt, Marjolijn Duijvestein, Parambir S Dulai, Johannes Grossmann, Robert P Hirten, Reena Khanna, Julian Panes, Laurent Peyrin-Biroulet, Miguel Regueiro, David T Rubin, Siddharth Singh, Ryan W Stidham, William J Sandborn, Brian G Feagan, Geert R D'Haens, Christopher Ma
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease. Inflammatory bowel diseases (2021)
Jordi Rimola, Agnès Fernàndez-Clotet, Nunzia Capozzi, Sònia Rojas-Farreras, Ignacio Alfaro, Sonia Rodríguez, Maria-Carme Masamunt, Elena Ricart, Ingrid Ordás, Julian Panes
Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease. Alimentary pharmacology & therapeutics 52 (10) (2020)
Amira Metwaly, Andreas Dunkel, Nadine Waldschmitt, Abilash Chakravarthy Durai Raj, Ilias Lagkouvardos, Ana Maria Corraliza, Aida Mayorgas, Margarita Martinez-Medina, Sinah Reiter, Michael Schloter, Thomas Hofmann, Matthieu Allez, Julian Panes, Azucena Salas, Dirk Haller
Integrated microbiota and metabolite profiles link Crohn's disease to sulfur metabolism. Nature communications 11 (1) (2020)
Damián García-Olmo, Gert Van Assche, Ignacio Tagarro, Mary Carmen Diez, Marie Paule Richard, Javaria Mona Khalid, Marc van Dijk, Dimitri Bennett, Suvi R K Hokkanen, Julian Panes
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis. Advances in therapy 36 (12) (2019)
Bruce E Sands, Alessandro Armuzzi, John K Marshall, James O Lindsay, William J Sandborn, Silvio Danese, Julian Panes, Brian Bressler, Jean Frederic Colombel, Nervin Lawendy, Eric Maller, Haiying Zhang, Gary Chan, Leonardo Salese, Konstantinos Tsilkos, Amy Marren, Chinyu Su
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open. Alimentary pharmacology & therapeutics 51 (2) (2019)
William J Sandborn, Julian Panes, Bruce E Sands, Walter Reinisch, Chinyu Su, Nervin Lawendy, Nana Koram, Haiyun Fan, Thomas V Jones, Irene Modesto, Daniel Quirk, Silvio Danese
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme. Alimentary pharmacology & therapeutics 50 (10) (2019)
Jordi Rimola, Almudena Alvarez-Cofiño, Tamara Pérez-Jeldres, Carmen Ayuso, Ignacio Alfaro, Sonia Rodríguez, Elena Ricart, Ingrid Ordás, Julian Panes
Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease. Journal of gastroenterology 52 (5) (2016)